stavudine has been researched along with Hypercholesterolemia in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arendt, V; Gilson, G; Moutschen, M; Mukeba-Tshialala, D; Mutombo-Tshingwali, M; Nachega, JB | 1 |
| Fekade, D; Feleke, Y; Mezegebu, Y | 1 |
| Bower, M; Gazzard, BG; Jackson, A; Jones, R; Mandalia, S; Michailidis, C; Moyle, GJ; Nelson, M; Sawleshwarkar, S; Stebbing, J | 1 |
| Anunnatsiri, S; Boonyaprawit, P; Chetchotisakd, P; Mootsikapun, P | 1 |
| Aurpibul, L; Lee, B; Mangklabruks, A; Puthanakit, T; Sirisanthana, T; Sirisanthana, V | 1 |
| Golk, M | 1 |
| Adorni, F; Corsico, L; d'Arminio Monforte, A; Galli, M; Gervasoni, C; Gianelli, E; Moroni, M; Piazza, M; Ravasio, L; Ridolfo, AL; Vaccarezza, M | 1 |
1 trial(s) available for stavudine and Hypercholesterolemia
| Article | Year |
|---|---|
Efficacy and safety of indinavir/ritonavir 400/100 mg twice daily plus two nucleoside analogues in treatment-naive HIV-1-infected patients with CD4+ T-cell counts <200 cells/mm3: 96-week outcomes.
Topics: Administration, Oral; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Drug Administration Schedule; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Hypercholesterolemia; Hyperglycemia; Hypertriglyceridemia; Indinavir; Lamivudine; Male; Ritonavir; RNA, Viral; Stavudine; Thailand; Treatment Outcome; Viral Load; Withholding Treatment | 2005 |
6 other study(ies) available for stavudine and Hypercholesterolemia
| Article | Year |
|---|---|
[Obesity, high blood pressure, hypercholesterolaemia, and untreated diabetes in HIV-infected and HIV-uninfected Adults in Mbuji-Mayi (Democratic republic of congo)].
Topics: Adult; Antiretroviral Therapy, Highly Active; Case-Control Studies; Cross-Sectional Studies; Delayed Diagnosis; Democratic Republic of the Congo; Diabetes Mellitus; Female; HIV Infections; HIV-1; Humans; Hypercholesterolemia; Hypertension; Lamivudine; Male; Middle Aged; Nevirapine; Obesity; Prevalence; Stavudine | 2017 |
Prevalence of highly active antiretroviral therapy associated metabolic abnormalities and lipodystrophy in HIV infected patients.
Topics: Adult; Aged, 80 and over; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Cross-Sectional Studies; Ethiopia; Female; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Hypercholesterolemia; Hyperglycemia; Hypertriglyceridemia; Interviews as Topic; Male; Metabolic Diseases; Middle Aged; Prevalence; Risk Factors; Stavudine; Surveys and Questionnaires; Zidovudine | 2012 |
Impact of antiretroviral choice on hypercholesterolaemia events: the role of the nucleoside reverse transcriptase inhibitor backbone.
Topics: Adult; Age Factors; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cholesterol; Epidemiologic Methods; Female; HIV Infections; HIV Protease Inhibitors; HIV Reverse Transcriptase; HIV-1; Humans; Hypercholesterolemia; Male; Middle Aged; Reverse Transcriptase Inhibitors; Stavudine | 2005 |
Lipodystrophy and metabolic changes in HIV-infected children on non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy.
Topics: Adolescent; Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; Child; Child, Preschool; Cyclopropanes; Female; HIV Infections; HIV-1; Humans; Hypercholesterolemia; Hyperglycemia; Hypertriglyceridemia; Lamivudine; Lipodystrophy; Male; Nevirapine; Prevalence; Reverse Transcriptase Inhibitors; Stavudine; Thailand | 2007 |
To AIDS and back with Norvir, D4T, 3TC and nutritional therapies. An interview with Michael Golk.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; CD4 Lymphocyte Count; Dietary Fats; Drug Therapy, Combination; HIV Protease Inhibitors; Humans; Hypercholesterolemia; Killer Cells, Natural; Lamivudine; Reverse Transcriptase Inhibitors; Ritonavir; Stavudine; Triglycerides | 1998 |
Body habitus changes and metabolic alterations in protease inhibitor-naive HIV-1-infected patients treated with two nucleoside reverse transcriptase inhibitors.
Topics: Adult; Aged; Anti-HIV Agents; Body Composition; Cohort Studies; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Hypercholesterolemia; Hyperglycemia; Male; Middle Aged; Retrospective Studies; Reverse Transcriptase Inhibitors; Stavudine; Triglycerides | 2002 |